STED and Device Master File: How to Organize Them to Avoid Rework

1. Key takeaways

What the EDE service page lists is the evidence that is needed, not how the evidence should be arranged. This is exactly where rework is most frequent: with the same set of materials, different ways of organizing them can double the number of deficiency requests. Our recommendation is to organize the technical documentation summary around the reference country approval documents as the main axis and the internationally common table-of-contents numbering as the skeleton, so that the reviewer completes the verification within a coordinate system they already know. From initial preparation to formal market entry typically takes 6–18 months (practical estimate), and rework is the main source of the variance within that range.

• The service page defines what evidence is needed but leaves the arrangement to the applicant.
• Organization quality directly drives the number of deficiency requests, which can vary by a factor of more than two.
• Use reference country approval documents as the main axis and internationally common numbering as the skeleton.
• From preparation to market entry typically takes 6–18 months, with rework as the main source of delay.
• A modular, individually numbered summary allows changes to be handled by replacing affected modules only.
• A complete index table at the front lets reviewers locate content quickly and lets deficiency responses point to specific items.
• Under reliance review, the reviewer works within the coordinate system of the reference country approvals, and the dossier should follow it.
• The Chinese NMPA documentation serves as supplementary corroboration of models, specifications, and technical parameters.
• Version dates on each module keep the record auditable across the 5-year validity period.
• Document format doubts are confirmed through EDE written channels rather than inferred from past experience.

2. Legal basis

The regulatory basis combines subparagraphs (c) and (h) of Article 6(1) of Federal Decree-Law No. 38 of 2024 with the document requirements of the EDE service page. The table below reproduces the instruments cited in the source material and their key points.

3. Expert insights

Insight 1: No mandatory format does not mean any format will do. Our judgment is that format freedom actually raises the organizational demands on the applicant. Adopting the internationally common technical documentation summary structure means the reviewer can locate content quickly and, when a deficiency arises, point precisely to an item instead of requiring the entire dossier to be resubmitted. Within the 45 working days review timeline, retrieval speed directly affects whether a deficiency request is issued.

Insight 2: Take reference country evidence as the main axis, not the Chinese registration file. Under reliance review, EDE takes account of approvals by the EMA, the US FDA, the UK MHRA, Australia’s TGA, Switzerland’s Swissmedic, Health Canada, and Japan’s MHLW and PMDA. Our arrangement is to place the reference country approval evidence in the central position and to use the Chinese NMPA file as supplementary corroboration of models, specifications, and technical parameters, so the reviewer never has to switch back and forth between two coordinate systems.

Insight 3: The technical documentation summary must be maintainable. The marketing authorization is valid for 5 years, and changes during that period are handled under Article 15. Our practice is to build the summary as a modular document, with each module independently numbered and marked with a version date, so that a change only replaces the affected modules while retaining a before-and-after comparison; the entire dossier is not rebuilt on every change.

4. Practical recommendations

• Adopt the internationally common technical documentation summary structure and place the table of contents and the document index at the front of the dossier.
• Organize the evidence around the reference country approval documents, using the Chinese NMPA file as supplementary corroboration of models and parameters.
• Present the safety and effectiveness data of Class III/IV devices in a dedicated chapter, not mixed with the general descriptive content.
• Number each module independently and mark its version date, so later changes can replace sections locally.
• Schedule from preparation to market entry at 6–18 months (practical estimate), with a separate buffer reserved for deficiency responses.
• Where the documentation format or table of contents is in doubt, confirm through EDE written channels rather than inferring from past experience.

5. Verification checklist

• □ The technical documentation summary uses a unified numbering system and contains a complete index table at the front
• □ The reference country approval documents are placed in the central position, with matching product names and models
• □ The safety and effectiveness data of Class III/IV devices form a dedicated, locatable chapter
• □ Every module carries a version number and date, with no contradictions between versions
• □ The classification conclusion, the intended use, and the technical parameters are stated consistently across at least three documents
• □ The schedule contains a buffer for deficiency responses, and the market entry date is not derived directly from the 45 working days

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team prepares MOHAP-compliant dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com